Skip to content

Home Blood Pressure Monitoring and blood pressure (BP) control

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN25105161
Enrollment
630
Registered
2003-09-08
Start date
2002-07-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension Circulatory System Hypertension

Interventions

Patients in the intervention group are provided with a home blood pressure monitor that they are to use at least once a week and report the BP measurements to their physician at each follow up visit.

Sponsors

Heart and Stroke Foundation of Ontario (Canada)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Adults (age 18 and older) who are patients of family physicians 2. Must be diagnosed with essential hypertension but not have yet achieved target levels

Exclusion criteria

Exclusion criteria: 1. A diagnosis of secondary hypertension 2. Pregnancy 3. Hypertension management primarily by a consultant 4. A disability that precludes use of a home blood pressure monitor 5. Enrolled in another hypertension trial 6. White coat hypertension

Design outcomes

Primary

MeasureTime frame
1. The mean daytime blood pressures on Ambulatory Blood Pressure Monitoring (ABPM) 2. The mean night-time blood pressures on ABPM 3. Achieving Blood Pressure (BP) target at end of study 4. Achieving 10% drop in the mean nighttime blood pressures

Secondary

MeasureTime frame
1. Patient lifestyle changes 2. The number of visits for hypertension 3. Compliance with hypertensive medication use 4. Compliance with the intervention 5. Intensity of treatment 6. Frequency of lifestyle counselling by physician 7. Quality of Life as measured by 36-item Short Form health survey (SF-36)

Countries

Canada

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026